Economic Burden of HIV in a Commercially Insured Population in the United States.

17 Previously, a retrospective analysis of US commercial insurance claims data from 2009 to 2014 found an increasing trend in prescriptions for PrEP; however, these are older data and warrant update. 18 Recent CDC reports estimate PrEP utilization among high-risk individuals for whom PrEP is indicated at 23% in 2019. 1 Annual costs for patients using HIV PrEP can be substantial, although estimates vary widely, perhaps

also in 63,971 other papers